Azenta AZTA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Azenta (AZTA)
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
Key Insights
Critical company metrics and information
Latest Closing Price
$43.68Market Cap
$2.14 BillionPrice-Earnings Ratio
-15.27Total Outstanding Shares
48.92 Million SharesTotal Employees
3,300Dividend
$0.10 Per Share QuarterlyIPO Date
February 1, 1995SIC Description
Special Industry Machinery, NecPrimary Exchange
NASDAQType
Common StockHeadquarters
200 summit drive, Burlington, MA, 01803Homepage
https://www.azenta.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $-370.14 Million |
Net Cash Flow From Financing Activities, Continuing | $-578.52 Million |
Net Cash Flow From Operating Activities | $76.49 Million |
Net Cash Flow From Investing Activities | $131.89 Million |
Net Cash Flow | $-370.14 Million |
Net Cash Flow From Investing Activities, Continuing | $131.89 Million |
Income Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Cost Of Revenue | $396.63 Million |
Revenues | $658.62 Million |
Operating Expenses | $467.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0 |
Gross Profit | $261.99 Million |
Operating Income/Loss | $-205.01 Million |
Comprehensive Income
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Other Comprehensive Income/Loss Attributable To Parent | $-7.75 Million |
Comprehensive Income/Loss | $-163.56 Million |
Comprehensive Income/Loss Attributable To Parent | $-163.56 Million |
Other Comprehensive Income/Loss | $-149.30 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Equity Attributable To Parent | $1.99 Billion |
Noncurrent Liabilities | $130.32 Million |
Assets | $2.32 Billion |
Liabilities | $332.90 Million |
Equity | $1.99 Billion |
Current Assets | $967.66 Million |
Historical Dividends
Current dividend: $0.10 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 10, 2021 | Dec 23, 2021 | Dec 3, 2021 | $0.1 | Quarterly |
Aug 5, 2021 | Sep 24, 2021 | Sep 3, 2021 | $0.1 | Quarterly |
Apr 27, 2021 | Jun 25, 2021 | Jun 4, 2021 | $0.1 | Quarterly |
Feb 2, 2021 | Mar 26, 2021 | Mar 5, 2021 | $0.1 | Quarterly |
Nov 10, 2020 | Dec 17, 2020 | Dec 4, 2020 | $0.1 | Quarterly |
Jul 30, 2020 | Sep 25, 2020 | Sep 4, 2020 | $0.1 | Quarterly |
Recent Headlines From The Web
Latest news, press releases, and media coverage about AZTA from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.